Universe Pharmaceuticals Stock Pattern Recognition Advance Block
| UPC Stock | USD 2.38 -0.27 -10.19% |
| Symbol |
Recognition |
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was twelve with a total number of output elements of forty-nine. The function did not return any valid pattern recognition events for the selected time horizon. The Advance Block describes upcoming bearish signal for Universe Pharmaceuticals.
Universe Pharmaceuticals Technical Analysis Modules
Most technical analysis of Universe Pharmaceuticals help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Universe from various momentum indicators to cycle indicators. When you analyze Universe charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Universe Pharmaceuticals Inc
Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited. Universe Pharmaceuticals is traded on NASDAQ Exchange in the United States. A high-level view of Universe Pharmaceuticals emphasizes earnings durability, balance-sheet flexibility, and competitive positioning. Current metrics include P/E of 3.02, P/B of 0.02, profit margin of -20.56%. Universe Pharmaceuticals has market cap of 1.34 M, P/E of 3.02, ROE of -7.23%.
Methodology
Unless otherwise specified, financial data for Universe Pharmaceuticals is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Universe (USA Stocks:UPC) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Information presented is compiled from public filings and market reference sources and official institutions such as U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO). Updates can be delayed depending on reporting conventions. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Universe Pharmaceuticals may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Universe Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Universe Pharmaceuticals' short interest history, or implied volatility extrapolated from Universe Pharmaceuticals options trading.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Macroaxis Index Invested few shares | |
 | Warren Buffett Holdings Invested over 60 shares | |
 | ESG Investing Invested few shares | |
 | Driverless Cars Invested over 200 shares | |
 | Investor Favorites Invested over 20 shares | |
 | Momentum Invested over 200 shares | |
 | Cash Cows Invested few shares | |
 | Hedge Favorites Invested over 200 shares | |
 | FinTech Invested over 20 shares | |
 | Advertising Invested few shares | |
 | Power Assets Invested over 200 shares | |
 | Blockchain Invested few shares |
More Resources for Universe Stock Analysis
Reviewing Universe Pharmaceuticals commonly begins with financial statements and performance trends. Key ratios help frame profitability, efficiency, and growth context for Universe Pharmaceuticals Stock. Below are reports that help frame Universe Pharmaceuticals Stock in context:Universe Pharmaceuticals has market cap of 1.34 M, P/E of 3.02, operating margin of -6.77%. See World Market Map for portfolio-level analysis. This suggests a position in Universe Pharmaceuticals across the allocation. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. Learn how to buy and trade Universe Stock using our step-by-step How to Buy Universe Pharmaceuticals guide.Analysis related to Universe Pharmaceuticals should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Quarterly Earnings Growth -0.82 | Earnings Share -8.06 | Revenue Per Share | Quarterly Revenue Growth -0.14 | Return On Assets |
Understanding Universe Pharmaceuticals includes distinguishing between market value and book value, where book value reflects Universe accounting equity. Universe Pharmaceuticals' market capitalization is 1.34 M. A P/B ratio of 0.02 suggests Universe Pharmaceuticals trades near or below book value. The intrinsic value concept focuses on underlying worth, which can diverge from market price and book value. Valuation work aligns these measures into a single context.
The concept of value for Universe Pharmaceuticals differs from its quoted price, since each reflects a different lens. For Universe Pharmaceuticals, key inputs include a P/E ratio of 3.02, a P/B ratio of 0.02, a profit margin of -20.56%, ROE of -7.23%. By contrast, market price reflects the level where buyers and sellers transact.